Raj Rai
Akorn CEO resigns after $4.3bn Fresenius deal falls through
December 10, 2018Sales and Marketing Akorn, CEO, Fresenius, M&A, MA, Raj Rai, court, generics
The CEO of American generics firm Akorn Inc has stepped down following a ruling from the Delaware Supreme Court declaring …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
